XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT).
Phase of Trial: Phase IV
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Everolimus (Primary) ; Sirolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Sponsors Abbott Vascular
- 04 Nov 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 09 Jun 2014 Planned End Date changed from 1 Feb 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
- 07 Oct 2013 Planned end date changed from 1 Oct 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov record.